I read the The Whole Food Guide to Strong Bones by Annemarie Colbin, Ph.D. at an interesting time in my life when it seems that more than ever my doctors want to push pills on me to prevent problems that may never exist anyway. (I received a complimentary copy of the book for review.)
The advice given in this book is often quite different from what you’d hear from your specialist or primary care doctor. I won’t say I agree 100% with everything Colbin says in her book, but she does present a different view than you’d normally hear in your …read more

People who live with celiac disease (Celiac Disease Awareness Month: October) may have yet something else to be concerned about: bone loss.
People with digestive disorders are prone to malnutrition because their bowels may not absorb the nutrients they need to be fully nourished. But there are other issues with celiac disease, researchers have found, issues such as antibodies forming that attack a protein responsible for bone health.
A study, published in the New England Journal of Medicine, has found that 20% of a study group of patients with celiac disease had this antibody. Researchers are looking at using medications that prevent …read more

The results of a three-year pivotal Phase 3 placebo-controlled trial evaluating denosumab in the treatment of bone loss in men undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer, showed positive top-line results.
Denosumab is the first fully human monoclonal antibody in late stage clinical development that specifically targets RANK Ligand, the essential regulator of osteoclasts (the cells that break down bone).
Amgen is studying denosumab in numerous tumor types across the spectrum of cancer induced bone disease.
Such were the findings recently reported by Amgen, Inc –maker of the bone loss drug denosumab.
In this study of more than 1,400 men, denosumab treatment …read more